News from the melanoma sessions of the European Cancer Congress 2017

During the European Cancer Congress, the melanoma sessions focused on practice changing trials. Recent developments and approvals in immunotherapy and targeted agents have significantly changed the landscape of melanoma therapy in the metastatic setting and provide great promise for adjuvant and neo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutkowski, Piotr, Kozak, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356268/
https://www.ncbi.nlm.nih.gov/pubmed/28302128
http://dx.doi.org/10.1186/s12916-017-0826-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356268/
https://www.ncbi.nlm.nih.gov/pubmed/28302128
http://dx.doi.org/10.1186/s12916-017-0826-4

Ejemplares similares